Acceleron Pharma (XLRN) PT Raised to $63 at Citi
Get Alerts XLRN Hot Sheet
Price: $178.75 --0%
Rating Summary:
11 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 15
Rating Summary:
11 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 15
Join SI Premium – FREE
Citi raised its price target on Acceleron Pharma (NASDAQ: XLRN) to $63.00 (from $44.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Upgrades DNB ASA (DNB:NO) (DNHBY) to Equalweight
- Xior Student Housing NV (XIOR:BB) PT Lowered to EUR37 at Morgan Stanley
- Citi Downgrades LexinFintech Holdings (ADR) (LX) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share